U.S. states claimed they are owed US$ 2.2 trillion to address harm from OxyContin maker Purdue Pharma LP’s alleged role in America’s opioid epidemic, accusing the drug-maker in new filings of pushing prescription painkillers on doctors and patients while playing down the risks of abuse and overdose.